IBDEI1HA ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24714,0)
 ;;=A60.04^^121^1222^55
 ;;^UTILITY(U,$J,358.3,24714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24714,1,3,0)
 ;;=3^Herpetic Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,24714,1,4,0)
 ;;=4^A60.04
 ;;^UTILITY(U,$J,358.3,24714,2)
 ;;=^5000356
 ;;^UTILITY(U,$J,358.3,24715,0)
 ;;=B39.3^^121^1222^57
 ;;^UTILITY(U,$J,358.3,24715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24715,1,3,0)
 ;;=3^Histoplasmosis,Disseminated
 ;;^UTILITY(U,$J,358.3,24715,1,4,0)
 ;;=4^B39.3
 ;;^UTILITY(U,$J,358.3,24715,2)
 ;;=^5000635
 ;;^UTILITY(U,$J,358.3,24716,0)
 ;;=B39.2^^121^1222^58
 ;;^UTILITY(U,$J,358.3,24716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24716,1,3,0)
 ;;=3^Histoplasmosis,Pulmonary
 ;;^UTILITY(U,$J,358.3,24716,1,4,0)
 ;;=4^B39.2
 ;;^UTILITY(U,$J,358.3,24716,2)
 ;;=^5000634
 ;;^UTILITY(U,$J,358.3,24717,0)
 ;;=A63.0^^121^1222^59
 ;;^UTILITY(U,$J,358.3,24717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24717,1,3,0)
 ;;=3^Human Papilloma Virus Infection NOS
 ;;^UTILITY(U,$J,358.3,24717,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,24717,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,24718,0)
 ;;=Z91.14^^121^1222^60
 ;;^UTILITY(U,$J,358.3,24718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24718,1,3,0)
 ;;=3^Hx of Past Medication Noncompliance
 ;;^UTILITY(U,$J,358.3,24718,1,4,0)
 ;;=4^Z91.14
 ;;^UTILITY(U,$J,358.3,24718,2)
 ;;=^5063616
 ;;^UTILITY(U,$J,358.3,24719,0)
 ;;=E78.5^^121^1222^61
 ;;^UTILITY(U,$J,358.3,24719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24719,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,24719,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,24719,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,24720,0)
 ;;=I10.^^121^1222^62
 ;;^UTILITY(U,$J,358.3,24720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24720,1,3,0)
 ;;=3^Hypertension,Unspec
 ;;^UTILITY(U,$J,358.3,24720,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,24720,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,24721,0)
 ;;=E29.1^^121^1222^92
 ;;^UTILITY(U,$J,358.3,24721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24721,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,24721,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,24721,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,24722,0)
 ;;=C46.7^^121^1222^63
 ;;^UTILITY(U,$J,358.3,24722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24722,1,3,0)
 ;;=3^Kaposi's Sarcoma NEC
 ;;^UTILITY(U,$J,358.3,24722,1,4,0)
 ;;=4^C46.7
 ;;^UTILITY(U,$J,358.3,24722,2)
 ;;=^5133326
 ;;^UTILITY(U,$J,358.3,24723,0)
 ;;=C46.0^^121^1222^64
 ;;^UTILITY(U,$J,358.3,24723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24723,1,3,0)
 ;;=3^Kaposi's Sarcoma,Skin
 ;;^UTILITY(U,$J,358.3,24723,1,4,0)
 ;;=4^C46.0
 ;;^UTILITY(U,$J,358.3,24723,2)
 ;;=^5001100
 ;;^UTILITY(U,$J,358.3,24724,0)
 ;;=K13.3^^121^1222^65
 ;;^UTILITY(U,$J,358.3,24724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24724,1,3,0)
 ;;=3^Leukoplakia,Oral Hairy
 ;;^UTILITY(U,$J,358.3,24724,1,4,0)
 ;;=4^K13.3
 ;;^UTILITY(U,$J,358.3,24724,2)
 ;;=^5008493
 ;;^UTILITY(U,$J,358.3,24725,0)
 ;;=R53.81^^121^1222^67
 ;;^UTILITY(U,$J,358.3,24725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24725,1,3,0)
 ;;=3^Malaise
 ;;^UTILITY(U,$J,358.3,24725,1,4,0)
 ;;=4^R53.81
 ;;^UTILITY(U,$J,358.3,24725,2)
 ;;=^5019518
 ;;^UTILITY(U,$J,358.3,24726,0)
 ;;=A31.0^^121^1222^68
 ;;^UTILITY(U,$J,358.3,24726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24726,1,3,0)
 ;;=3^Mycobacteria,Atypical,Pulmonary
 ;;^UTILITY(U,$J,358.3,24726,1,4,0)
 ;;=4^A31.0
 ;;^UTILITY(U,$J,358.3,24726,2)
 ;;=^5000149
 ;;^UTILITY(U,$J,358.3,24727,0)
 ;;=A31.8^^121^1222^69
 ;;^UTILITY(U,$J,358.3,24727,1,0)
 ;;=^358.31IA^4^2
